JP Morgan Chase
TFFP

JP Morgan Chase’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

JP Morgan Chase’s Portfolio TFFP Stock Details TFFP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-400
Closed -$57K – 6945
2022
Q2 		$57K Hold
400
– – ﹤0.01% 5621
2022
Q1 		$63K Hold
400
– – ﹤0.01% 5707
2021
Q4 		$89K Buy
+400
New +$77.4K ﹤0.01% 5736

Other funds holding TFFP

CC
Carlson Capital Dallas, Texas $494M AUM 23.45% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $4.11B AUM 21.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NL
NWAM LLC Mercer Island, Washington $2B AUM 34.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

JP Morgan Chase's TFFP Position: Q2 2024 in Review

JP Morgan Chase sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q2 2024, closing a stake of 5 shares — an estimated $31 sold.

JP Morgan Chase first reported a position in TFFP in Q1 2021 and held it in 9 quarters. The position peaked at $601K in Q3 2021. 21 funds tracked by Wall St. Rank hold TFFP as of Q2 2024.

  • JP Morgan Chase reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • JP Morgan Chase sold 5 TFF Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $31.
  • JP Morgan Chase first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q1 2021 and held it in 9 quarters.
  • JP Morgan Chase's TFF Pharmaceuticals, Inc. Common Stock position peaked at $601K in Q3 2021.
  • 21 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on JP Morgan Chase's 13F filing for Q2 2024, filed 12 Aug 2024.